No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2591983 |
chr5:16150721-16150722 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs2591984 |
chr5:16150723-16150724 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs146955047 |
chr5:16150775-16150776 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs551030144 |
chr5:16150905-16150906 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs569001633 |
chr5:16150939-16150940 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs536026742 |
chr5:16150991-16150992 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs3910978 |
chr5:16151004-16151005 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs559224849 |
chr5:16151017-16151018 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs577266709 |
chr5:16151021-16151022 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs76836761 |
chr5:16151081-16151082 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs559808924 |
chr5:16151089-16151090 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs558232634 |
chr5:16151159-16151160 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs576756370 |
chr5:16151160-16151161 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs188418908 |
chr5:16151164-16151165 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs556220610 |
chr5:16151237-16151238 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs146885845 |
chr5:16151301-16151302 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs79830066 |
chr5:16151348-16151349 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs555308094 |
chr5:16151373-16151374 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs145808380 |
chr5:16151375-16151376 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs540648994 |
chr5:16151392-16151393 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs11955448 |
chr5:16151496-16151497 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs565161475 |
chr5:16151603-16151604 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs75290131 |
chr5:16151614-16151615 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs111683651 |
chr5:16151668-16151669 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs145242773 |
chr5:16151693-16151694 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs371044597 |
chr5:16151709-16151710 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs180780847 |
chr5:16151725-16151726 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs148381429 |
chr5:16151730-16151731 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs529842405 |
chr5:16151742-16151743 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs184958307 |
chr5:16151745-16151746 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs189800110 |
chr5:16151748-16151749 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs113095621 |
chr5:16151759-16151760 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs70938045 |
chr5:16151798-16151799 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs58891017 |
chr5:16151801-16151802 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs552547940 |
chr5:16151848-16151849 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs9312907 |
chr5:16151881-16151882 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs552427547 |
chr5:16151897-16151898 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs7726990 |
chr5:16151976-16151977 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs112407988 |
chr5:16151992-16151993 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs66468106 |
chr5:16151993-16151994 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs181747265 |
chr5:16152036-16152037 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs555994712 |
chr5:16152089-16152090 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs370066922 |
chr5:16152136-16152137 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs530126391 |
chr5:16152162-16152163 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs1561637 |
chr5:16152168-16152169 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs567161927 |
chr5:16152201-16152202 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs531589110 |
chr5:16152280-16152281 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs367871075 |
chr5:16152317-16152318 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs368353463 |
chr5:16152372-16152373 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs149177621 |
chr5:16152382-16152383 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|